The deal gives Boston Scientific a 34% equity stake in MiRus and an option to acquire its TAVR platform by making additional ...

Boston Scientific may acquire full ownership of MiRus’ TAVR business for an additional $3bn after achieving certain ...

The deal gives Boston Scientific a 34% stake in MiRus and an option to buy its TAVR business for an additional $3 billion ...

May 18 (Reuters) - U.S. medical device maker Boston Scientific said on Monday it has invested $1.5 billion in privately held ...

Boston Scientific has signed a $2 billion accelerated share-repurchase agreement with JPMorgan Chase as part of the medical-technology company's $5 billion stock-buyback program. Boston Scientific on ...

Boston Scientific invests $1.5B in Georgia startup MiRus for a 34% stake and exclusive rights to acquire its heart valve ...

Boston Scientific (BSX) stock is in focus as its SEISMIQ 4CE catheter hit safety and efficacy endpoints in trial for ...

BostonSci secures rights to acquire MiRus' SIEGEL TAVR system with $1.5B equity stake and potential buyout, marking its 3rd ...

The Food and Drug Administration has issued a Class I recall correction for certain Boston Scientific ACCOLADE pacemakers and cardiac resynchronization therapy pacemakers after identifying a software- ...

Boston Scientific recalls pacemakers due to battery issues causing safety mode activation linked to 4 deaths and 2,557 serious injuries, FDA reports.

CVS Health, headquartered in Woonsocket, Rhode Island, has named Boston Scientific Chairman and CEO Michael Mahoney to its board of directors, effective November 1. “Mike’s focus throughout his career ...